831 related articles for article (PubMed ID: 18413304)
1. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
2. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
Ahmad S; Ahmed A
Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis.
Ahmad S; Ahmed A
Endothelium; 2005; 12(1-2):89-95. PubMed ID: 16036320
[TBL] [Abstract][Full Text] [Related]
6. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
8. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
9. Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells.
Romani F; Lanzone A; Tropea A; Tiberi F; Catino S; Apa R
Placenta; 2011 Feb; 32(2):153-60. PubMed ID: 21145589
[TBL] [Abstract][Full Text] [Related]
10. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
[TBL] [Abstract][Full Text] [Related]
11. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
[TBL] [Abstract][Full Text] [Related]
12. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of Vegfr-2 and its soluble form in preeclampsia.
Munaut C; Lorquet S; Pequeux C; Coulon C; Le Goarant J; Chantraine F; Noël A; Goffin F; Tsatsaris V; Subtil D; Foidart JM
PLoS One; 2012; 7(3):e33475. PubMed ID: 22428059
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.
Li H; Gu B; Zhang Y; Lewis DF; Wang Y
Placenta; 2005; 26(2-3):210-7. PubMed ID: 15708122
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
[TBL] [Abstract][Full Text] [Related]
17. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
Soto E; Romero R; Kusanovic JP; Ogge G; Hussein Y; Yeo L; Hassan SS; Kim CJ; Chaiworapongsa T
J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
[TBL] [Abstract][Full Text] [Related]
19. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.
Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S
Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584
[TBL] [Abstract][Full Text] [Related]
20. Role of extracellular signal-regulated kinase and AKT cascades in regulating hypoxia-induced angiogenic factors produced by a trophoblast-derived cell line.
Fujita D; Tanabe A; Sekijima T; Soen H; Narahara K; Yamashita Y; Terai Y; Kamegai H; Ohmichi M
J Endocrinol; 2010 Jul; 206(1):131-40. PubMed ID: 20371567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
